Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study

E. Geoffrey Playford, Trent P. Munro, Stephen M. Mahler, Suzanne Elliott, Michael Gerometta, Kym Hoger, Martina L. Jones, Paul Griffin, Kathleen D. Lynch, Heidi Carroll, Debra El Saadi, Margaret E. Gilmour, Benjamin Hughes, Karen Hughes, Edwin Huang, Christopher J. de Bakker, Reuben Klein, Mark G. Scher, Ina Smith, Lin‐Fa Wang, Stephen B. Lambert, Dimiter S. Dimitrov, Peter P. Gray, Christopher C. Broder